Combinatorial interactions of genetic variants in human cardiomyopathy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30923642.
- Also identified by DOI 10.1038/s41551-019-0348-9 and PMC identifier 6433174.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dilated cardiomyopathy (DCM) is a leading cause of morbidity and mortality worldwide; yet how genetic variation and environmental factors impact DCM heritability remains unclear. Here, we report that compound genetic interactions between DNA sequence variants contribute to the complex heritability of DCM. By using genetic data from a large family with a history of DCM, we discovered that heterozygous sequence variants in the <i>TROPOMYOSIN 1</i> (<i>TPM1</i>) and <i>VINCULIN</i> (<i>VCL</i>) genes cose-gregate in individuals affected by DCM. In vitro studies of patient-derived and isogenic human-pluripotent-stem-cell-derived cardio-myocytes that were genome-edited via CRISPR to create an allelic series of <i>TPM1</i> and <i>VCL</i> variants revealed that cardiomyocytes with both <i>TPM1</i> and <i>VCL</i> variants display reduced contractility and sarcomeres that are less organized. Analyses of mice genetically engineered to harbour these human <i>TPM1</i> and <i>VCL</i> variants show that stress on the heart may also influence the variable penetrance and expressivity of DCM-associated genetic variants in vivo. We conclude that compound genetic variants can interact combinatorially to induce DCM, particularly when influenced by other disease-provoking stressors.
Medical subject headings
- Cardiomyopathy, Dilated
- Genetic Predisposition to Disease
- Genetic Variation